CHESS ROBERT 4
4 · Twist Bioscience Corp · Filed Nov 13, 2024
Insider Transaction Report
Form 4
CHESS ROBERT
Director
Transactions
- Exercise/Conversion
Common Stock
2024-11-11$8.82/sh+3,600$31,752→ 25,241 total - Sale
Common Stock
2024-11-11$46.99/sh−2,324$109,203→ 22,917 total - Sale
Common Stock
2024-11-11$47.76/sh−1,276$60,935→ 21,641 total - Exercise/Conversion
Stock Option (right to buy)
2024-11-11−3,600→ 3,504 totalExercise: $8.82Exp: 2027-09-28→ Common Stock (3,600 underlying)
Holdings
- 42,528(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 12, 2024.
- [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $46.50 to $47.44 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F3]Represents the weighted average sales price per share. The shares sold at prices ranging from $47.50 to $47.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F4]The Reporting Person and his spouse are the sole trustees and the sole beneficiaries of the Chess 1997 Trust.
- [F5]The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date